The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Synergy Biomedical sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Synergy Biomedical is a medical equipment company that develops biomaterial-based products for the orthopaedic and spinal markets. The company’s Biosphere technology represents an innovative approach to advancing bone graft technology and improving bone healing and patient outcomes. Its product portfolio includes putty, MIS, MIS II, Flex SP, and Flex SP extremities. Synergy Biomedical is headquartered in Wayne, Pennsylvania, the US.
The key metrics of Synergy Biomedical related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Synergy Biomedical is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Synergy Biomedical.
For a detailed understanding of the performance of Synergy Biomedical, buy the report here.